Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting

Maria Sanali M O Paiva, Carlos V. Serrano, José Carlos Nicolau, Bruna O. Jalbut, Juliano L. Fernandes, James A de Lemos, Maria Heloísa S L Blotta, Rômulo T D De Oliveira, Itamar R. De Oliveira, Ludmilla Da A R R De Oliveira, José Antônio F Ramires

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Patients with diabetes mellitus who undergo coronary stenting are at increased risk of restenosis. It is known that inflammation plays a crucial role in restenosis. Objective: We assessed the inflammatory response to elective coronary stent implantation (CSI) in stable diabetic and nondiabetic patients. Methods: C-reactive protein (CRP), soluble (s) P-selectin, and soluble intercellular adhesion molecule (sICAM)-1 plasma levels were determined in diabetic (n = 51) and nondiabetic (n = 56) patients before and 48 hours and 4 weeks after bare metal stenting (BMS). Results: Diabetic patients presented significantly higher inflammatory marker levels before and after CSI. Nonetheless, diabetic and nondiabetic patients had postintervention peak of markers attained within 48 hours. At baseline, diabetic and nondiabetic patients presented CRP levels of 5.0 ± 20.1 (P ≤ 0.04) and 3.8 ± 9.4 μg/ml and, at 48 hours postintervention, 22.0 ± 20.2 (P = 0.001; P = 0.002) and 12.6 ± 11.3 (P ≤ 0.0001) μg/ml. Regarding sP-selectin, diabetic and nondiabetic patients obtained levels of, at baseline, 182 ± 118 (P ≤ 0.04) and 105 ± 48 ng/ml and, at 48 hours, 455 ± 290 (P = 0.001; P ≤ 0.01) and 215 ± 120 (P ≤ 0.04) ng/ml. For diabetic and nondiabetic patients, sICAM-1 levels were, at baseline, 248 ± 98 (P ≤ 0.04) and 199 ± 94 ng/ml and, at 48 hours, 601 ± 201 (P = 0.001; P ≤ 0.01) and 283 ± 220 (P = 0.001) ng/ml. At 4 weeks, for all patients, markers returned to preprocedural levels: versus before PCI: *P = 0.001, §P ≤ 0.0001; versus nondiabetic patients: #P ≤ 0.04, P = 0.002, ΥP ≤ 0.01. Conclusions: Diabetic and nondiabetic patients exhibited a temporal inflammatory response after an elective BMS. However, diabetic patients present higher preprocedural levels of CRP, sP-selectin, and sICAM-1 and reveal a further exacerbated inflammatory response after intervention. The differences in inflammatory response may have implications in restenosis within these two sets of patients.

Original languageEnglish (US)
Pages (from-to)403-409
Number of pages7
JournalJournal of Interventional Cardiology
Volume21
Issue number5
DOIs
StatePublished - Oct 2008

Fingerprint

Diabetes Mellitus
Intercellular Adhesion Molecule-1
C-Reactive Protein
Selectins
Stents
Metals
P-Selectin
Inflammation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting. / Paiva, Maria Sanali M O; Serrano, Carlos V.; Nicolau, José Carlos; Jalbut, Bruna O.; Fernandes, Juliano L.; de Lemos, James A; Blotta, Maria Heloísa S L; De Oliveira, Rômulo T D; De Oliveira, Itamar R.; De Oliveira, Ludmilla Da A R R; Ramires, José Antônio F.

In: Journal of Interventional Cardiology, Vol. 21, No. 5, 10.2008, p. 403-409.

Research output: Contribution to journalArticle

Paiva, MSMO, Serrano, CV, Nicolau, JC, Jalbut, BO, Fernandes, JL, de Lemos, JA, Blotta, MHSL, De Oliveira, RTD, De Oliveira, IR, De Oliveira, LDARR & Ramires, JAF 2008, 'Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting', Journal of Interventional Cardiology, vol. 21, no. 5, pp. 403-409. https://doi.org/10.1111/j.1540-8183.2008.00385.x
Paiva, Maria Sanali M O ; Serrano, Carlos V. ; Nicolau, José Carlos ; Jalbut, Bruna O. ; Fernandes, Juliano L. ; de Lemos, James A ; Blotta, Maria Heloísa S L ; De Oliveira, Rômulo T D ; De Oliveira, Itamar R. ; De Oliveira, Ludmilla Da A R R ; Ramires, José Antônio F. / Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting. In: Journal of Interventional Cardiology. 2008 ; Vol. 21, No. 5. pp. 403-409.
@article{50ef8828bca240dbb1e840d9ca303c61,
title = "Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting",
abstract = "Background: Patients with diabetes mellitus who undergo coronary stenting are at increased risk of restenosis. It is known that inflammation plays a crucial role in restenosis. Objective: We assessed the inflammatory response to elective coronary stent implantation (CSI) in stable diabetic and nondiabetic patients. Methods: C-reactive protein (CRP), soluble (s) P-selectin, and soluble intercellular adhesion molecule (sICAM)-1 plasma levels were determined in diabetic (n = 51) and nondiabetic (n = 56) patients before and 48 hours and 4 weeks after bare metal stenting (BMS). Results: Diabetic patients presented significantly higher inflammatory marker levels before and after CSI. Nonetheless, diabetic and nondiabetic patients had postintervention peak of markers attained within 48 hours. At baseline, diabetic and nondiabetic patients presented CRP levels of 5.0 ± 20.1 (P ≤ 0.04) and 3.8 ± 9.4 μg/ml and, at 48 hours postintervention, 22.0 ± 20.2 (P = 0.001; P = 0.002) and 12.6 ± 11.3 (P ≤ 0.0001) μg/ml. Regarding sP-selectin, diabetic and nondiabetic patients obtained levels of, at baseline, 182 ± 118 (P ≤ 0.04) and 105 ± 48 ng/ml and, at 48 hours, 455 ± 290 (P = 0.001; P ≤ 0.01) and 215 ± 120 (P ≤ 0.04) ng/ml. For diabetic and nondiabetic patients, sICAM-1 levels were, at baseline, 248 ± 98 (P ≤ 0.04) and 199 ± 94 ng/ml and, at 48 hours, 601 ± 201 (P = 0.001; P ≤ 0.01) and 283 ± 220 (P = 0.001) ng/ml. At 4 weeks, for all patients, markers returned to preprocedural levels: versus before PCI: *P = 0.001, §P ≤ 0.0001; versus nondiabetic patients: #P ≤ 0.04, ¶P = 0.002, ΥP ≤ 0.01. Conclusions: Diabetic and nondiabetic patients exhibited a temporal inflammatory response after an elective BMS. However, diabetic patients present higher preprocedural levels of CRP, sP-selectin, and sICAM-1 and reveal a further exacerbated inflammatory response after intervention. The differences in inflammatory response may have implications in restenosis within these two sets of patients.",
author = "Paiva, {Maria Sanali M O} and Serrano, {Carlos V.} and Nicolau, {Jos{\'e} Carlos} and Jalbut, {Bruna O.} and Fernandes, {Juliano L.} and {de Lemos}, {James A} and Blotta, {Maria Helo{\'i}sa S L} and {De Oliveira}, {R{\^o}mulo T D} and {De Oliveira}, {Itamar R.} and {De Oliveira}, {Ludmilla Da A R R} and Ramires, {Jos{\'e} Ant{\^o}nio F}",
year = "2008",
month = "10",
doi = "10.1111/j.1540-8183.2008.00385.x",
language = "English (US)",
volume = "21",
pages = "403--409",
journal = "Journal of Interventional Cardiology",
issn = "0896-4327",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting

AU - Paiva, Maria Sanali M O

AU - Serrano, Carlos V.

AU - Nicolau, José Carlos

AU - Jalbut, Bruna O.

AU - Fernandes, Juliano L.

AU - de Lemos, James A

AU - Blotta, Maria Heloísa S L

AU - De Oliveira, Rômulo T D

AU - De Oliveira, Itamar R.

AU - De Oliveira, Ludmilla Da A R R

AU - Ramires, José Antônio F

PY - 2008/10

Y1 - 2008/10

N2 - Background: Patients with diabetes mellitus who undergo coronary stenting are at increased risk of restenosis. It is known that inflammation plays a crucial role in restenosis. Objective: We assessed the inflammatory response to elective coronary stent implantation (CSI) in stable diabetic and nondiabetic patients. Methods: C-reactive protein (CRP), soluble (s) P-selectin, and soluble intercellular adhesion molecule (sICAM)-1 plasma levels were determined in diabetic (n = 51) and nondiabetic (n = 56) patients before and 48 hours and 4 weeks after bare metal stenting (BMS). Results: Diabetic patients presented significantly higher inflammatory marker levels before and after CSI. Nonetheless, diabetic and nondiabetic patients had postintervention peak of markers attained within 48 hours. At baseline, diabetic and nondiabetic patients presented CRP levels of 5.0 ± 20.1 (P ≤ 0.04) and 3.8 ± 9.4 μg/ml and, at 48 hours postintervention, 22.0 ± 20.2 (P = 0.001; P = 0.002) and 12.6 ± 11.3 (P ≤ 0.0001) μg/ml. Regarding sP-selectin, diabetic and nondiabetic patients obtained levels of, at baseline, 182 ± 118 (P ≤ 0.04) and 105 ± 48 ng/ml and, at 48 hours, 455 ± 290 (P = 0.001; P ≤ 0.01) and 215 ± 120 (P ≤ 0.04) ng/ml. For diabetic and nondiabetic patients, sICAM-1 levels were, at baseline, 248 ± 98 (P ≤ 0.04) and 199 ± 94 ng/ml and, at 48 hours, 601 ± 201 (P = 0.001; P ≤ 0.01) and 283 ± 220 (P = 0.001) ng/ml. At 4 weeks, for all patients, markers returned to preprocedural levels: versus before PCI: *P = 0.001, §P ≤ 0.0001; versus nondiabetic patients: #P ≤ 0.04, ¶P = 0.002, ΥP ≤ 0.01. Conclusions: Diabetic and nondiabetic patients exhibited a temporal inflammatory response after an elective BMS. However, diabetic patients present higher preprocedural levels of CRP, sP-selectin, and sICAM-1 and reveal a further exacerbated inflammatory response after intervention. The differences in inflammatory response may have implications in restenosis within these two sets of patients.

AB - Background: Patients with diabetes mellitus who undergo coronary stenting are at increased risk of restenosis. It is known that inflammation plays a crucial role in restenosis. Objective: We assessed the inflammatory response to elective coronary stent implantation (CSI) in stable diabetic and nondiabetic patients. Methods: C-reactive protein (CRP), soluble (s) P-selectin, and soluble intercellular adhesion molecule (sICAM)-1 plasma levels were determined in diabetic (n = 51) and nondiabetic (n = 56) patients before and 48 hours and 4 weeks after bare metal stenting (BMS). Results: Diabetic patients presented significantly higher inflammatory marker levels before and after CSI. Nonetheless, diabetic and nondiabetic patients had postintervention peak of markers attained within 48 hours. At baseline, diabetic and nondiabetic patients presented CRP levels of 5.0 ± 20.1 (P ≤ 0.04) and 3.8 ± 9.4 μg/ml and, at 48 hours postintervention, 22.0 ± 20.2 (P = 0.001; P = 0.002) and 12.6 ± 11.3 (P ≤ 0.0001) μg/ml. Regarding sP-selectin, diabetic and nondiabetic patients obtained levels of, at baseline, 182 ± 118 (P ≤ 0.04) and 105 ± 48 ng/ml and, at 48 hours, 455 ± 290 (P = 0.001; P ≤ 0.01) and 215 ± 120 (P ≤ 0.04) ng/ml. For diabetic and nondiabetic patients, sICAM-1 levels were, at baseline, 248 ± 98 (P ≤ 0.04) and 199 ± 94 ng/ml and, at 48 hours, 601 ± 201 (P = 0.001; P ≤ 0.01) and 283 ± 220 (P = 0.001) ng/ml. At 4 weeks, for all patients, markers returned to preprocedural levels: versus before PCI: *P = 0.001, §P ≤ 0.0001; versus nondiabetic patients: #P ≤ 0.04, ¶P = 0.002, ΥP ≤ 0.01. Conclusions: Diabetic and nondiabetic patients exhibited a temporal inflammatory response after an elective BMS. However, diabetic patients present higher preprocedural levels of CRP, sP-selectin, and sICAM-1 and reveal a further exacerbated inflammatory response after intervention. The differences in inflammatory response may have implications in restenosis within these two sets of patients.

UR - http://www.scopus.com/inward/record.url?scp=52649125611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649125611&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8183.2008.00385.x

DO - 10.1111/j.1540-8183.2008.00385.x

M3 - Article

VL - 21

SP - 403

EP - 409

JO - Journal of Interventional Cardiology

JF - Journal of Interventional Cardiology

SN - 0896-4327

IS - 5

ER -